Nakai Miho, Okada Yosuke, Tanikawa Takahisa, Kanda Kazuko, Morita Emiko, Tanaka Yoshiya
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
J UOEH. 2003 Sep 1;25(3):333-9. doi: 10.7888/juoeh.25.333.
Graves' ophthalmopathy in hypothyroid state is called Hypothyroid Graves' Disease, which is a comparatively rare disease. We experienced a case of a 57 year old man with severe exophthalmos and diplopia, which are typical symptoms of Graves' opthalmopathy, and with an extremely high thyroid-stimulating antibody(TSAb) level. He also had a firm diffuse goiter and hypothyroidism with positive anti-thyroglobulin and anti-thyroid microsomal antigen. These findings suggested Hashimoto's thyroiditis. Severity of ophthalmopathy and TSAb level were improved during replacement therapy with T4. Although a thyroid stimulation-blocking antibody was also detected in this patient, we thought that hypothyroidism in this case was based on destructive change in the thyroid with Hashimoto's thyroiditis. Therefore, we should be aware of the fact that there are cases of hypothyroidism with Graves' ophthalmopathy and a high level of TSAb.
甲状腺功能减退状态下的格雷夫斯眼病被称为甲状腺功能减退性格雷夫斯病,这是一种相对罕见的疾病。我们遇到了一名57岁男性患者,他有严重眼球突出和复视,这是格雷夫斯眼病的典型症状,且甲状腺刺激抗体(TSAb)水平极高。他还有质地坚硬的弥漫性甲状腺肿以及甲状腺功能减退,抗甲状腺球蛋白和抗甲状腺微粒体抗原呈阳性。这些发现提示为桥本甲状腺炎。在使用T4替代治疗期间,眼病的严重程度和TSAb水平有所改善。尽管该患者也检测到了甲状腺刺激阻断抗体,但我们认为该病例中的甲状腺功能减退是基于桥本甲状腺炎导致的甲状腺破坏性改变。因此,我们应该意识到存在伴有格雷夫斯眼病和高水平TSAb的甲状腺功能减退病例。